Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.

Crowd of people blurred image

The alternative approach to clinical practice, published in The Lancet Psychiatry, was developed by health practitioners and suicide prevention experts, together with a service user.

The new guidance is intended to reduce risk through a person-centred strategy in which assessment is regarded as a therapeutic process which is aimed at identifying interventions to enhance well-being, together with an individualised safety plan developed collaboratively with the patient.

Professor Keith Hawton CBE, Professor of Psychiatry and Director of the Centre for Suicide Research at Oxford University, and a lead author on the article, said:

'A substantial proportion of individuals who die by suicide each year have been suffering from mental illness. Therefore prevention of suicide is one key task of mental health practitioners, but traditionally this has been dominated by attempts to predict suicide risk. Our approach, which is more focussed on a therapeutic approach to addressing risk, should greatly improve patient care, with likely benefits for suicide prevention.'

Karen Lascelles, Nurse Consultant at Oxford Health NHS Foundation Trust, and joint lead author of the article, said:

 

'This therapeutic and collaborative approach to patient safety can help clinicians, patients and patients' families gain a better understanding of when and why a patient might become vulnerable, and what the patient and those involved in their care can do to help keep them safe. It should be taught to clinicians during their training and in practice, and supported by organisations and regulators.'

Steve Gilbert, OBE, another author of the article, said:

 

'As a suicide attempt survivor of multiple episodes, I know all too well the heart-breaking agony of being told you are at "low risk of suicide" based on the risk prediction methodology. The importance of a clinician meeting me where I am, acknowledging my situation, and working with me to understand the ways in which we can collectively keep me safe cannot be underestimated. I believe that a therapeutic and empathetic assessment can be the starting point for a life-saving relationship.'

The authors highlight the fact that extensive evidence from several countries shows that prediction of risk largely doesn't work. They also point out that preoccupation with risk prediction may undermine efforts to help patients with their problems, which has been highlighted by both family members and patients themselves.

The full paper, Assessment of suicide risk in mental health practice: Shifting from prediction to therapeutic assessment, formulation and risk management, can be read in The Lancet Psychiatry.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Engagement with arts and culture can have a positive impact on mental health in young people

A new study finds that engaging with arts and culture online can improve mental health in young people.

Increased Risk of Some Neurological and Psychiatric Disorders Remains 2 Years After COVID-19 Infection

New study from the University of Oxford and the National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre investigated neurological and psychiatric diagnoses in over 1.25 million people following diagnosed COVID-19 infection, using data from the US-based TriNetX electronic health record network.

Alcohol affects the Human Biological Clock

The short-term effects of excessive drinking are well known, but to date it has been less certain whether alcohol also accelerates the aging process.

New Meta-Analysis Highlights No Antidepressant Effect of Statins Administered in Monotherapy

This new systematic review and meta-analysis of randomised controlled trials assesses the effects of statins given alone, without concomitant antidepressant treatment, in people with depressive symptoms, but who do not have a formal diagnosis of a depressive disorder.

New Oxford Study Evaluates Pharmacological Treatment for Insomnia

Two drugs, eszopiclone and lemborexant – both not currently licenced for the treatment of insomnia in the UK – were shown to perform better than others, both in the acute and long-term treatment of insomnia in adults, according to a new Oxford study exploring the pharmacological management of insomnia.